表紙
市場調査レポート

気道感染症:世界の治験レビュー

Respiratory Tract Infections Global Clinical Trials Review, H2, 2015

発行 GlobalData 商品コード 224009
出版日 ページ情報 英文 390 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.95円で換算しております。
Back to Top
気道感染症:世界の治験レビュー Respiratory Tract Infections Global Clinical Trials Review, H2, 2015
出版日: 2015年11月25日 ページ情報: 英文 390 Pages
概要

当レポートでは、世界各国における気道感染症の臨床試験について調査し、地域・進捗状況・フェーズ(相)・募集状況別の実施件数や、代表的なスポンサー、開発中の治療薬の情報、各企業・機関での進行状況といった情報を盛り込んで、概略以下の構成でお届けします。

  • 目次
    • イントロダクション
      • 気道感染症
      • レポートガイダンス
    • 臨床試験 地域別
    • 臨床試験 国別
      • 臨床試験に寄与している上位5ヵ国 − アジア太平洋地域
      • 臨床試験に寄与している上位5ヵ国 − 欧州
      • 臨床試験に寄与している上位国 − 北米
      • 臨床試験に寄与している上位5ヵ国 − 中東およびアフリカ
      • 臨床試験に寄与している上位5ヵ国 − 中南米
    • 臨床試験 − BRIC諸国
    • 臨床試験 − G7 諸国
    • 臨床試験 − G7 諸国 治験ステータス別
    • 臨床試験 − E7 諸国
    • 臨床試験 − E7 諸国 治験ステータス別
    • 臨床試験 相別
      • 進行中の治験 相別
    • 臨床試験 治験ステータス別
    • 未完了の治験
    • 期間ごとの被験者数
    • 有力なスポンサー
      • 参加上位企業
    • 有望な治療薬比較
    • 臨床試験プロファイル
      • 臨床試験概要:上位企業
        • GlaxoSmithKline plc
        • Sanofi
        • Pfizer Inc.
        • MedImmune, LLC
        • Johnson & Johnson
        • Abbott Laboratories
        • AstraZeneca PLC
        • Merck & Co., Inc.
        • Bayer AG
        • Venus Remedies Limited
        • Theravance, Inc.
        • Novartis AG
        • 第一三共
        • Danone Research B.V.
        • U.S. Bioscience, Inc
        • Biological E. Limited
        • Immtech Pharmaceuticals, Inc.
        • Shantha Biotechnics Limited
        • Jacobus Pharmaceutical Company
        • Bristol-Myers Squibb Company
      • 臨床試験概要:トップレベルの大学 / 研究機関 / 病院
        • The National Institute of Allergy and Infectious Diseases
        • University Hospital Basel
        • The University of Southampton
        • 東北大学
        • ICDDR,B
        • Department of Health
        • NEOCI
        • St. Marianna University School of Medicine
        • Assistance Publique - Hopitaux de Paris
        • 長崎大学
        • University of Pittsburgh
        • Washington University School of Medicine
        • Centers for Disease Control and Prevention
        • Chinese University of Hong Kong
        • University of Oxford
        • University of Milan
        • Rambam Health Care Campus
        • Centre for International Health
        • SOCIETY FOR APPLIED STUDIES
        • 小野市民病院
    • 主要5件の臨床プロファイル

    付録

    図表一覧


  • このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

    目次
    Product Code: GDHC2960CTIDB

    GlobalData's clinical trial report, "Respiratory Tract Infections Global Clinical Trials Review, H2, 2015" provides an overview of Respiratory Tract Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Respiratory Tract Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

    The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

    Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

    Scope

    • The report provides a snapshot of the global clinical trials landscape
    • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
    • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
    • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
    • The Report provides enrollment trends for the past five years
    • Report provides latest news for the past three months

    Reasons to buy

    • Assists in formulating key business strategies with regards to investment
    • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
    • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
    • Supports understanding of trials count and enrollment trends by country in global therapeutics market
    • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
    • Facilitates clinical trial assessment of the indication on a global, regional and country level

    Table of Contents

    • Table of Contents
      • List of Tables
      • List of Figures
    • Report Guidance
    • Clinical Trials by Region
      • Clinical Trials and Average Enrollment by Country
        • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
        • Top Five Countries Contributing to Clinical Trials in Europe
        • Top Countries Contributing to Clinical Trials in North America
        • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
        • Top Five Countries Contributing to Clinical Trials in Central and South America
    • Clinical Trials by G7 Countries: Proportion of Respiratory Tract Infections to Respiratory Clinical Trials
    • Clinical Trials by Phase in G7 Countries
    • Clinical Trials in G7 Countries by Trial Status
    • Clinical Trials by E7 Countries: Proportion of Respiratory Tract Infections to Respiratory Clinical Trials
    • Clinical Trials by Phase in E7 Countries
    • Clinical Trials in E7 Countries by Trial Status
    • Clinical Trials by Phase
      • In Progress Trials by Phase
    • Clinical Trials by Trial Status
    • Clinical Trials by End Point Status
    • Subjects Recruited Over a Period of Time
    • Clinical Trials by Sponsor Type
    • Prominent Sponsors
      • Top Companies Participating in Respiratory Tract Infections Therapeutics Clinical Trials
    • Prominent Drugs
    • Clinical Trial Profile Snapshots
    • Appendix
      • Abbreviations
      • Definitions
      • Research Methodology
      • Secondary Research
      • About GlobalData
      • Contact Us
      • Disclaimer
      • Source

    List of Tables

    • Respiratory Tract Infections Therapeutics, Global, Clinical Trials by Region, 2015*
    • Respiratory Tract Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
    • Respiratory Tract Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
    • Respiratory Tract Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
    • Respiratory Tract Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
    • Respiratory Tract Infections Therapeutics Clinical Trials, North America, Top Countries, 2015*
    • Respiratory Tract Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015*
    • Respiratory Tract Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015*
    • Proportion of Respiratory Tract Infections to Respiratory Clinical Trials, G7 Countries (%), 2015*
    • Respiratory Tract Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
    • Respiratory Tract Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
    • Proportion of Respiratory Tract Infections to Respiratory Clinical Trials, E7 Countries (%), 2015*
    • Respiratory Tract Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
    • Respiratory Tract Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
    • Respiratory Tract Infections Therapeutics, Global, Clinical Trials by Phase, 2015*
    • Respiratory Tract Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
    • Respiratory Tract Infections Therapeutics, Global, Clinical Trials by Trial Status, 2015*
    • Respiratory Tract Infections Therapeutics Clinical Trials, Global, by End Point Status, 2015*
    • Respiratory Tract Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
    • Respiratory Tract Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
    • Respiratory Tract Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
    • Respiratory Tract Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
    • Respiratory Tract Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*

    List of Figures

    • Respiratory Tract Infections Therapeutics, Global, Clinical Trials by Region (%), 2015*
    • Respiratory Tract Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
    • Respiratory Tract Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
    • Respiratory Tract Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
    • Respiratory Tract Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
    • Respiratory Tract Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
    • Respiratory Tract Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015*
    • Respiratory Tract Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015*
    • Proportion of Respiratory Tract Infections to Respiratory Clinical Trials, G7 Countries (%), 2015*
    • Respiratory Tract Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
    • Respiratory Tract Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
    • Proportion of Respiratory Tract Infections to Respiratory Clinical Trials, E7 Countries (%), 2015*
    • Respiratory Tract Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
    • Respiratory Tract Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
    • Respiratory Tract Infections Therapeutics, Global, Clinical Trials by Phase (%), 2015*
    • Respiratory Tract Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
    • Respiratory Tract Infections Therapeutics, Global, Clinical Trials by Trial Status, 2015*
    • Respiratory Tract Infections Therapeutics Clinical Trials, Global, by End Point Status, 2015*
    • Respiratory Tract Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
    • Respiratory Tract Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
    • Respiratory Tract Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
    • Respiratory Tract Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
    • Respiratory Tract Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
    • GlobalData Methodology
    Back to Top